CAMP4 Therapeutics Corporation Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| 5AM VENTURE MANAGEMENT, LLC | 11/14/2025 | 5.87 M | $17.61 M | 100.45% | 29.11% |
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 4.64 M | $13.92 M | 100.00% | 23.02% |
| VIVO CAPITAL, LLC | 11/14/2025 | 3.92 M | $11.76 M | 100.00% | 19.45% |
| ENAVATE SCIENCES GP, LLC | 11/14/2025 | 3.79 M | $11.36 M | 0.00% | 18.78% |
| FMR LLC | 11/13/2025 | 3.02 M | $9.07 M | 397.32% | 15.00% |
| AH CAPITAL MANAGEMENT, L.L.C. | 11/14/2025 | 2.13 M | $6.38 M | 0.00% | 10.54% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 1.96 M | $5.88 M | 100.00% | 9.73% |
| HARBOURVEST PARTNERS LLC | 11/14/2025 | 1.27 M | $3.82 M | 0.00% | 6.31% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/12/2025 | 653.59 K | $1.96 M | 100.00% | 3.24% |
| VANGUARD GROUP INC | 11/07/2025 | 313.51 K | $940.52 K | -4.68% | 1.56% |
| ALYESKA INVESTMENT GROUP, L.P. | 11/17/2025 | 200.00 K | $600.00 K | 0.00% | 0.99% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 97.37 K | $292.11 K | 100.00% | 0.48% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 95.07 K | $285.21 K | -28.54% | 0.47% |
| VICTORY CAPITAL MANAGEMENT INC | 11/12/2025 | 82.79 K | $248.37 K | -0.33% | 0.41% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 60.37 K | $181.11 K | -19.72% | 0.30% |
| STATE STREET CORP | 11/14/2025 | 26.00 K | $78.00 K | 100.00% | 0.13% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 25.00 K | $75.00 K | 0.00% | 0.12% |
| MARINER, LLC | 11/14/2025 | 17.30 K | $51.89 K | 100.00% | 0.09% |
| NORTHERN TRUST CORP | 11/14/2025 | 14.62 K | $43.85 K | 0.00% | 0.07% |
| BLACKROCK, INC. | 11/12/2025 | 11.44 K | $34.31 K | -86.42% | 0.06% |
| UBS GROUP AG | 11/13/2025 | 7.04 K | $21.13 K | 38.42% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 5.65 K | $16.95 K | 47.49% | 0.03% |
| ROYAL BANK OF CANADA | 11/14/2025 | 953 | $3.00 K | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 283 | $849 | -56.60% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 78 | $234 | -81.73% | 0.00% |
| BARCLAYS PLC | 11/12/2025 | 70 | $210 | 100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 15 | $45 | -25.00% | 0.00% |
| MORGAN STANLEY | 11/14/2025 | 3 | $9 | -99.82% | 0.00% |
| JPMORGAN CHASE & CO | 11/26/2025 | 0 | $0 | -100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 10/23/2025 | 0 | $0 | -100.00% | 0.00% |
| CANTOR FITZGERALD, L. P. | 12/01/2025 | 0 | $0 | -100.00% | 0.00% |
| VERITION FUND MANAGEMENT LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 11/10/2025 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
CAMP4 Therapeutics Corporation institutional Ownership - FAQ's
During the previous two years, 94 institutional investors and hedge funds held shares of CAMP4 Therapeutics Corporation. The most heavily invested institutionals were:
5AM Venture Management, LLC: 5.87 M
JANUS HENDERSON GROUP PLC: 4.64 M
Vivo Capital, LLC: 3.92 M
Enavate Sciences GP, LLC: 3.79 M
FMR LLC: 3.02 M
AH Capital Management, L.L.C.: 2.13 M
139.93% of CAMP4 Therapeutics Corporation stock is owned by institutional investors.
Institutional investors have bought a total of 36.08 M shares in the last 24 months. This purchase volume represents approximately $109.33 M in transactions.